Nevertheless, modulating and mitigating ROS production via MSCs may be an interesting starting point for further in-vivo research studies involving established mouse models of mitochondrial NDUFS4 deficiency. The gene discussed is NDUFS4; the disease is hyperinsulinemic hypoglycemia, familial, 4.